Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MEDX Stock Forecast 2026-2027
$33.43
Current Price
$0
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MEDX Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
MEDX Price Momentum
+0.6%
1 Week Change
+4.8%
1 Month Change
+31.1%
1 Year Change
+0.7%
Year-to-Date Change
-5.7%
From 52W High of $35.46
+34.9%
From 52W Low of $24.79
📊 TOP ANALYST CALLS
Did MEDX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Horizon Kinetics MED ETF is one of their latest high-conviction picks.
Latest MEDX Stock Price Targets & Analyst Predictions
MEDX has shown a year-to-date change of 0.7% and a 1-year change of 31.1%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MEDX. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MEDX Analyst Ratings
0
Buy
0
Hold
0
Sell
MEDX Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $33.43
Latest MEDX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MEDX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 22, 2022 | Truist Securities | Hold | Maintains | $N/A | |
| Nov 23, 2021 | HSBC | Hold | Initiates | $N/A | |
| Nov 17, 2021 | RBC Capital | Sector Perform | Maintains | $N/A | |
| Nov 11, 2021 | Jefferies | Hold | Upgrade | $N/A | |
| May 21, 2020 | SunTrust Robinson Humphrey | Buy | Maintains | $N/A | |
| May 11, 2020 | SunTrust Robinson Humphrey | Buy | Maintains | $N/A | |
| Apr 13, 2020 | SunTrust Robinson Humphrey | Buy | Maintains | $N/A | |
| Feb 21, 2020 | CFRA | Buy | Upgrade | $N/A | |
| Jan 21, 2020 | Jefferies | Buy | Upgrade | $N/A | |
| Oct 23, 2019 | Redburn | Neutral | Downgrade | $N/A | |
| Aug 1, 2019 | BTIG | Neutral | Downgrade | $N/A | |
| Jun 20, 2019 | Barclays | Overweight | Upgrade | $N/A | |
| Oct 26, 2018 | UBS | Buy | Upgrade | $N/A | |
| Oct 18, 2018 | DZ Bank | Hold | Downgrade | $N/A | |
| Aug 28, 2018 | HSBC | Buy | Upgrade | $N/A | |
| Apr 24, 2018 | Deutsche Bank | Buy | Upgrade | $N/A | |
| Mar 17, 2016 | Nomura | Buy | Initiates | $N/A | |
| Jan 5, 2016 | UBS | Buy | Upgrade | $N/A | |
| Oct 30, 2015 | SunTrust Robinson Humphrey | Buy | Maintains | $N/A | |
| Oct 30, 2015 | PiperJaffray | Neutral | Maintains | $N/A |
Horizon Kinetics Medical ETF (MEDX) Competitors
The following stocks are similar to Horizon Kinetics MED ETF based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
MEDX
Horizon Kinetics
mkt cap
16.75B
Horizon Kinetics Medical ETF (MEDX) Financial Data
Horizon Kinetics Medical ETF has a market capitalization of $0 with a P/E ratio of 26.1x. The company generates $17.62B in trailing twelve-month revenue with a 28.8% profit margin.
Revenue growth is +7.1% quarter-over-quarter, while maintaining an operating margin of +10.9% and return on equity of +9.9%.
Valuation Metrics
Market Cap
$0
Enterprise Value
$11.84B
P/E Ratio
26.1x
PEG Ratio
N/A
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
+7.1%
Gross Margin
+26.7%
Operating Margin
+10.9%
Net Margin
+28.8%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
N/A
Current Ratio
3.7x
Debt/Equity
1.2x
ROE
+9.9%
ROA
+2.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Horizon Kinetics Medical ETF (MEDX) Business Model
About Horizon Kinetics Medical ETF
What They Do
Provides exposure to the healthcare sector.
Business Model
The ETF generates revenue by pooling investor capital to invest in a diversified portfolio of healthcare-related companies, including those in biotechnology, pharmaceuticals, and medical devices. It allows investors to gain exposure to the healthcare sector without the need to select individual stocks, capitalizing on the growth of innovative companies in medical research and development.
Additional Information
Managed by Horizon Kinetics, known for its analytical investment strategies, the fund aims to address public health challenges and capitalize on advancements in medical technology. This ETF is suitable for investors looking to benefit from the healthcare industry's significance in the global economy.
Horizon Kinetics Medical ETF (MEDX) Latest News & Analysis
Latest News
Medical ETF (MEDX) Touches New 52-Week High
1 month ago
Quick Summary
MEDX reaches a new 52-week high, driven by strong performance in its patented pharmaceutical products.
Why It Matters
MEDX's 52-week high signals strong market confidence and potential for continued growth, driven by its patented pharma, which can attract more investment and increase stock value.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Eli Lilly (LLY) has increased its 2024 outlook due to strong sales growth of its new obesity drug Zepbound and diabetes drug Mounjaro.
Why It Matters
Eli Lilly's raised outlook signals strong revenue growth potential, driven by successful drug sales, which may enhance stock performance and investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Eli Lilly (LLY) reported strong Q4 2023 earnings, exceeding estimates due to robust sales of diabetes and weight-loss treatments.
Why It Matters
Eli Lilly's strong Q4 earnings and sales beat indicate robust demand for its diabetes and weight-loss drugs, suggesting potential for continued revenue growth and stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Eli Lilly Beats on Q3 Earnings: ETFs to Buy
2 years ago
Quick Summary
Eli Lilly (LLY) reported strong Q3 2023 earnings, exceeding estimates for revenue and profit, with continued strong performance from its Mounjaro anti-obesity drug.
Why It Matters
Eli Lilly's strong earnings and Mounjaro's success indicate solid growth potential, positively impacting investor confidence and stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Eli Lilly's stock surged significantly after a strong Q2 2023 earnings report and positive outlook. ETFs with high exposure to the company may be attractive investment options.
Why It Matters
Eli Lilly's stock surge signals strong financial health and growth potential, making ETFs with exposure to the company attractive for capitalizing on this momentum.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
The Oakmark Intl Small Cap Fund updated its portfolio for the fiscal quarter ending March 31. The fiscal year concludes in September.
Why It Matters
Portfolio updates reveal fund performance and investment strategy shifts, impacting investor confidence and potential stock movements. Key for assessing fund health and market trends.
Source: GuruFocus
Market Sentiment:
Positive
Frequently Asked Questions About MEDX Stock
What is Horizon Kinetics Medical ETF's (MEDX) stock forecast for 2026?
Analyst forecasts for Horizon Kinetics Medical ETF (MEDX) are not currently available. The stock is trading at $33.43.
Is MEDX stock a good investment in 2026?
Analyst ratings for MEDX are not currently available. The stock is currently trading at $33.43. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MEDX stock?
Price predictions from Wall Street analysts for MEDX are not currently available. The stock is trading at $33.43.
What is Horizon Kinetics Medical ETF's business model?
The ETF generates revenue by pooling investor capital to invest in a diversified portfolio of healthcare-related companies, including those in biotechnology, pharmaceuticals, and medical devices. It allows investors to gain exposure to the healthcare sector without the need to select individual stocks, capitalizing on the growth of innovative companies in medical research and development.
What is the highest forecasted price for MEDX Horizon Kinetics Medical ETF?
Price targets from Wall Street analysts for MEDX are not currently available. The stock is trading at $33.43.
What is the lowest forecasted price for MEDX Horizon Kinetics Medical ETF?
Price targets from Wall Street analysts for MEDX are not currently available. The stock is trading at $33.43.
What is the overall MEDX consensus from analysts for Horizon Kinetics Medical ETF?
Analyst ratings for MEDX are not currently available. The stock is trading at $33.43.
How accurate are MEDX stock price projections?
Stock price projections, including those for Horizon Kinetics Medical ETF, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 20, 2026 3:20 AM UTC